FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...